TMC was delighted to have participated at BIO-Europe 2023, the annual conference held this year in Munich from the 6-8 November, where it attracted 5,500 attendees from 2,500 representing companies covering 65 countries. Delegates from the life sciences community attended insightful presentations that provided an overview of the latest trends, challenges and opportunities in the rapidly evolving biotech landscape.
“This was our first participation at this Conference and we were so impressed by its organisation and ease of setting up partnering and networking opportunities and fostering some great collaboration with industry professionals.” Commented Stewart Sharpe, TMC’s Chief Commercial Officer.
For more information about our CRO expertise in orphan and rare diseases and to discuss how we can support you in the early pre-clinical phase right through to post-marketing please contact us.